LPTX Leap Therapeutics Inc
10,408
$2.78
$0.13
(4.47%)
| Watchers | 10,408 |
| 52-Wk Low | $1.24 |
| 52-Wk High | $10.20 |
| Market Cap | $106.38M |
| Volume | 125,413.00 |
| 52-Wk High | $10.20 |
| 52-Wk Low | $1.24 |
Leap Therapeutics Announces $40 Million Private PlacementPR Newswire • 30 days ago
Leap Therapeutics Announces $40 Million Private Placement Leap Therapeutics Announces $40 Million Private Placement PR Newswire CAMBRIDGE, Mass., April 11, 2024 Net proceeds, along with existing...
Share to Feed
Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results Leap Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire CAMBRIDGE, Mass., March 18...
Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe Study at the 2024 ASCO Gastrointestinal Cancers Symposium Leap Therapeutics to Present New Clinical Data from Part A of DeFianCe...
Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference Leap Therapeutics to Participate at the 42nd Annual J.P. Morgan Healthcare Conference PR Newswire CAMBRIDGE...
Leap Therapeutics Announces Completion of Enrollment in Randomized Controlled Part C of the DisTinGuish Study of DKN-01 for the Treatment of Gastric Cancer Patients Leap Therapeutics Announces...